Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

ACS highlights: DuPont investigates dual MMP/TNF-alpha production inhibitors

Aug. 24, 1999

Korean researchers identify antiinflammatory/analgesic agent from native shrub extract

Aug. 24, 1999

Anika completes patient enrollment in Orthovisc phase III trial

Aug. 24, 1999

Fuji Pharmaceutical describes therapeutic activity of dual MMP/TACE inhibitors

Aug. 19, 1999

Etanercept trial results in psoriatic arthritis announced

Aug. 18, 1999

COX-2 inhibitor research continues at Searle

Aug. 17, 1999

Iomed begins phase III trials of IontoDex for inflammation

Aug. 16, 1999

MMP-3-selective matrix metalloproteinase inhibitors discovered at Pfizer

Aug. 13, 1999

Phase II trial commences for Alexion's C5 complement inhibitor in RA

Aug. 12, 1999

Novel NSAIDs synthesized and evaluated at Ortho-McNeil

Aug. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...